In the past year, nearly a dozen companies have taken advantage of new rules to list on the Stock Exchange of Hong Kong Limited (HKEx). On April 30, 2018, HKEx introduced a series of reforms to encourage the listing of...more
6/19/2019
/ Biotechnology ,
China ,
Corporate Executives ,
Dual Class Share Structures ,
EU ,
Food and Drug Administration (FDA) ,
HKEx ,
Hong Kong Stock Exchange ,
Innovative Technology ,
Listing Rules ,
Patent Registration ,
Popular ,
Publicly-Traded Companies ,
Research and Development ,
Shareholders ,
Threshold Requirements ,
United States ,
Weighted Voting Rights (WVR)
In April 2018, the Hong Kong Stock Exchange’s (HKEx) rule amendments permitting the listing of innovative, high-growth companies with dual-class share structures and pre-revenue biotech companies went into effect. The...more
1/23/2019
/ Biotechnology ,
Capital Markets ,
Capital Raising ,
China ,
Dual Class Share Structures ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Shanghai Stock Exchange ,
Shenzhen Stock Exchange (SZSE) ,
Stock Connect ,
Technology Sector ,
Trade Relations
In an important development for the Hong Kong securities market, the Hong Kong Stock Exchange (HKEx) announced that it has reached an agreement with the Shanghai and Shenzhen Stock Exchanges to permit companies with...more
After publishing the “New Board Concept Paper” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued a consultation paper on February 23, 2018, titled “A Listing Regime for Companies From Emerging...more
4/26/2018
/ Biotechnology ,
China ,
Corporate Governance ,
Dual Class Share Structures ,
Emerging Technology Companies ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Innovation ,
Listing Rules ,
Publicly-Traded Companies ,
Research and Development ,
Secondary Listings ,
Shareholder Rights ,
Voting Rights
After publishing the “New Board Concept Paper Conclusions” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued on 23 February 2018 a consultation paper entitled “A Listing Regime for Companies From...more
2/26/2018
/ Biotechnology ,
China ,
Corporate Governance ,
Dual Class Share Structures ,
Emerging Technology Companies ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Innovation ,
Investor Protection ,
Issuer Eligibility Criteria ,
Listing Rules ,
Publicly-Traded Companies ,
Research and Development ,
Secondary Listings ,
Shareholder Rights ,
Technology Sector ,
Voting Rights ,
Waivers